TCM
Tamarack Capital Management Portfolio holdings
AUM
$503M
This Quarter Return
+0.8%
1 Year Return
+15.45%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$362M
AUM Growth
+$362M
(+23%)
Cap. Flow
+$73.7M
Cap. Flow
% of AUM
20.39%
Top 10 Holdings %
Top 10 Hldgs %
67.06%
Holding
33
New
9
Increased
13
Reduced
5
Closed
3
Top Buys
| 1 |
SPNC
Spectranetics Corp
SPNC
|
$14.3M |
| 2 |
ELGX
Endologix Inc
ELGX
|
$13.4M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$13.3M |
| 4 |
AEGR
Aegerion Pharmaceuticals, Inc.
AEGR
|
$11.7M |
| 5 |
Ironwood Pharmaceuticals
IRWD
|
$11.5M |
Top Sells
| 1 |
INSY
Insys Therapeutics, Inc.
INSY
|
$19.8M |
| 2 |
BMR
BIOMED REALTY TRUST INC
BMR
|
$11.3M |
| 3 |
CONMED
CNMD
|
$6.19M |
| 4 |
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
|
$3.36M |
| 5 |
NXTM
NxStage Medical Inc.
NXTM
|
$2.03M |
Sector Composition
| 1 | Healthcare | 68.18% |
| 2 | Technology | 3.44% |
| 3 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Bio-Rad Laboratories Class A
BIO
$8.06B
| $1.93M | 0.39% | +16,369 | New | +$1.93M |
|
|
AMAG
27
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $1.22M | 0.25% | +64,080 | New | +$1.22M |
|
28
iShares Russell 2000 ETF
IWM
$67B
| – | – | 0 | – | – |
|
29
Johnson & Johnson
JNJ
$427B
| – | – | 0 | – | – |
|
30
SPDR S&P 500 ETF Trust
SPY
$658B
| – | – | 0 | – | – |
|
|
OXFD
31
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| – | – | -167,625 | Closed | -$3.36M |
|
|
INSY
32
DELISTED
Insys Therapeutics, Inc.
INSY
| – | – | -477,141 | Closed | -$19.8M |
|
|
BMR
33
DELISTED
BIOMED REALTY TRUST INC
BMR
| – | – | -550,000 | Closed | -$11.3M |
|